Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today reported results for the quarter ended June 30, 2013.
“Net revenue of $4.9 billion was in-line with the previous quarter, and we are pleased with increased sales in our Specialty franchise, as well as in our OTC business,” said Jeremy Levin, Teva’s President and Chief Executive Officer.
Help employers find you! Check out all the jobs and post your resume.
